Ivet Elias

Bellaterra, CT 08193, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.

AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 11, 2025

Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.

Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 01, 2024

Overexpressing high levels of human vaspin limits high fat diet-induced obesity and enhances energy expenditure in a transgenic mouse.

Overexpressing high levels of human vaspin limits high fat diet-induced obesity and enhances energy expenditure in a transgenic mouse.

Journal: Frontiers in endocrinology

Published: January 17, 2023

Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver.

Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver.

Journal: PloS one

Published: May 29, 2020

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice.

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice.

Journal: Molecular metabolism

Published: October 30, 2019

FGF21 gene therapy as treatment for obesity and insulin resistance.

FGF21 gene therapy as treatment for obesity and insulin resistance.

Journal: EMBO molecular medicine

Published: July 11, 2018

Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.

Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.

Journal: Molecular therapy. Methods & clinical development

Published: March 22, 2017

BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue.

BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue.

Journal: Cell reports

Published: January 13, 2017

AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance.

AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance.

Journal: Molecular therapy. Methods & clinical development

Published: July 29, 2016

The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review.

The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review.

Journal: Actas dermo-sifiliograficas

Published: January 26, 2016

ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.

ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.

Journal: Diabetes

Published: January 08, 2016

Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.

Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.

Journal: Actas dermo-sifiliograficas

Published: November 20, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026